Oxygen Saturation and Pulse Rate Change in Children during Sedation with Oral Midazolam and Nitrous Oxide

Objective: We aimed to examine if changes in oxygen saturation and pulse rate of pediatric patients during conscious sedation with midazolam and nitrous oxide are associated with child's behavior, midazolam dose, the type and duration of the treatment and demographic parameters. Study Design: This study was a retrospective chart review of consecutive pediatric patients, aged 2.5–12.5 years, who had undergone conscious sedation for dental treatment with oral midazolam (with or without nitrous oxide) between January 2011 and September 2015 at the Department of Pediatric Dentistry of Tel Aviv University. Oral midazolam was administered according to the patients' weight, either at 0.4 mg/kg, 0.5 mg/kg or at a maximum dose of 10 mg. In all cases pulse rate and oxygen saturation were monitored every 15 minutes during treatment, Results: 147 sedation sessions (82 of females and 65 of males) were included in the study. Sedation was successful in 80% of cases. Children with poor behavior scores had statistically significant different mean saturation levels, albeit within normal range, during the treatment (p<0.012) as well as a clinically significant higher mean pulse rate (p=0.0001), compared to children with good or excellent behavior scores. Treatment duration, the type of dental procedure or the patients' weight were not correlated with the change in oxygen saturation or pulse rate during the treatment. Conclusions: Poor behavior of pediatric patients does not affect oxygen saturation, but it increases the pulse rate of children under sedation with midazolam and nitrous oxide.

Sedation, Midazolam, Nitrous Oxide

1. Azevedo ID, Ferreira MA, da Costa AP, Bosco VL, Moritz RD. Efficacy and safety of midazolam for sedation in pediatric dentistry: a controlled clinical trial. J Dent Child (Chic);80:133-138. 2013.

2. Clinical Affairs Committee-Behavior Management Subcommittee AAPD. Guideline on Behavior Guidance for the Pediatric Dental Patient. Pediatr Dent;37:57-70. 2015.

3. Hallonsten A-L, Jensen B, Raadal M, Veerkamp J, Hosey MT, Poulsen S. EAPD Guidelines on Sedation in Paediatric Dentistry. 2013.

4. Malamed SF. Sedation: A Guide to Patient Management. 5 edn. New York, NY: CV Mosby-Year Book Inc; 2010.

5. Kupietzky A, Houpt MI. Midazolam: a review of its use for conscious seda-tion of children. Pediatr Dent;15:237-241. 1993.

6. Grogan K, Nyhan D, Berkowitz DE. Pharmacology of Anesthetic Drugs In: Essentials of Cardiac Anesthesia. Kaplan JA (ed.); 1st ED.;WB Saunders, Philadelphia.; 2008

7. Keerthy HP, Balakrishna R, Srungeri KM, Singhvi N, John J, Islam M. Comparitive Evaluation of Propofol and Midazolam as Conscious Seda-tives in Minor Oral Surgery. J Maxillofac Oral Surg;14:773-783. 2015.

8. Saxen MA. Pharmacologic Management of Patient Behavior. In: McDonald and Avery’sDentistry for the Child and Adolescent, Dean JA (ed.); 10th ED; St. Louis, MO,: 303-327. 2016.

9. Chowdhury J, Vargas KG. Comparison of chloral hydrate, meperidine, and hydroxyzine to midazolam regimens for oral sedation of pediatric dental patients. Pediatr Dent;27:191-197. 2005.

10. Isik B, Baygin O, Kapci EG, Bodur H. The effects of temperament and behaviour problems on sedation failure in anxious children after midaz-olam premedication. Eur J Anaesthesiol;27:336-340. 2010.

11. Fraone G, Wilson S, Casamassimo PS, Weaver J, 2nd, Pulido AM. The effect of orally administered midazolam on children of three age groups during restorative dental care. Pediatr Dent;21:235-241. 1999.

12. Singh N, Pandey RK, Saksena AK, Jaiswal JN. A comparative evaluation of oral midazolam with other sedatives as premedication in pediatric dentistry. J Clin Pediatr Dent;26:161-164. 2002.

13. Somri M, Parisinos CA, Kharouba J, Cherni N, Smidt A, Abu Ras Z, Darawshi G, Gaitini LA. Optimising the dose of oral midazolam sedation for dental procedures in children: a prospective, randomised, and controlled study. Int J Paediatr Dent;22:271-279. 2012.